#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Interview with Reggie Bibbs on his life with neurofibromatosis
1-1	0-9	Interview	event[1]	new[1]	_	_
1-2	10-14	with	event[1]	new[1]	_	_
1-3	15-21	Reggie	event[1]|person[2]	new[1]|new[2]	coref	18-1[99_2]
1-4	22-27	Bibbs	event[1]|person[2]	new[1]|new[2]	_	_
1-5	28-30	on	event[1]|person[2]	new[1]|new[2]	_	_
1-6	31-34	his	event[1]|person[2]|abstract[3]	new[1]|new[2]|new[3]	_	_
1-7	35-39	life	event[1]|person[2]|abstract[3]	new[1]|new[2]|new[3]	_	_
1-8	40-44	with	event[1]|person[2]|abstract[3]	new[1]|new[2]|new[3]	_	_
1-9	45-62	neurofibromatosis	event[1]|person[2]|abstract[3]|abstract	new[1]|new[2]|new[3]|new	coref	3-5

#Text=Friday , December 14 , 2007
2-1	63-69	Friday	time	new	appos	2-3[7_0]
2-2	70-71	,	_	_	_	_
2-3	72-80	December	time|time[7]	new|giv[7]	_	_
2-4	81-83	14	time[7]	giv[7]	_	_
2-5	84-85	,	time[7]	giv[7]	_	_
2-6	86-90	2007	time[7]|time	giv[7]|new	_	_

#Text=Infobox : What is neurofibromatosis ?
3-1	91-98	Infobox	object	new	coref	19-26
3-2	99-100	:	_	_	_	_
3-3	101-105	What	_	_	_	_
3-4	106-108	is	_	_	_	_
3-5	109-126	neurofibromatosis	abstract	giv	coref	4-1
3-6	127-128	?	_	_	_	_

#Text=Neurofibromatosis ( NF ) is a genetic condition causing benign tumors ( neurofibromas ) to grow along certain types of nerves and , in addition , it can affect the development of bones or skin .
4-1	129-146	Neurofibromatosis	abstract	giv	appos	4-3
4-2	147-148	(	_	_	_	_
4-3	149-151	NF	abstract	giv	coref	4-6[13_0]
4-4	152-153	)	_	_	_	_
4-5	154-156	is	_	_	_	_
4-6	157-158	a	abstract[13]	giv[13]	ana	4-27[0_13]
4-7	159-166	genetic	abstract[13]	giv[13]	_	_
4-8	167-176	condition	abstract[13]	giv[13]	_	_
4-9	177-184	causing	_	_	_	_
4-10	185-191	benign	object[14]	new[14]	coref	7-22[39_14]
4-11	192-198	tumors	object[14]	new[14]	_	_
4-12	199-200	(	_	_	_	_
4-13	201-214	neurofibromas	_	_	_	_
4-14	215-216	)	_	_	_	_
4-15	217-219	to	_	_	_	_
4-16	220-224	grow	_	_	_	_
4-17	225-230	along	_	_	_	_
4-18	231-238	certain	place[15]	new[15]	_	_
4-19	239-244	types	place[15]	new[15]	_	_
4-20	245-247	of	place[15]	new[15]	_	_
4-21	248-254	nerves	place[15]|abstract	new[15]|new	coref	16-17[91_0]
4-22	255-258	and	_	_	_	_
4-23	259-260	,	_	_	_	_
4-24	261-263	in	_	_	_	_
4-25	264-272	addition	_	_	_	_
4-26	273-274	,	_	_	_	_
4-27	275-277	it	abstract	giv	coref	5-6[22_0]
4-28	278-281	can	_	_	_	_
4-29	282-288	affect	_	_	_	_
4-30	289-292	the	event[18]	new[18]	_	_
4-31	293-304	development	event[18]	new[18]	_	_
4-32	305-307	of	event[18]	new[18]	_	_
4-33	308-313	bones	event[18]|object	new[18]|new	_	_
4-34	314-316	or	event[18]	new[18]	_	_
4-35	317-321	skin	event[18]|object	new[18]|new	coref	7-8[32_0]
4-36	322-323	.	_	_	_	_

#Text=There are several variants of the disease but type 1 and type 2 NF account for the vast majority of cases .
5-1	324-329	There	_	_	_	_
5-2	330-333	are	_	_	_	_
5-3	334-341	several	object[21]	new[21]	_	_
5-4	342-350	variants	object[21]	new[21]	_	_
5-5	351-353	of	object[21]	new[21]	_	_
5-6	354-357	the	object[21]|abstract[22]|abstract[23]	new[21]|giv[22]|new[23]	coref|coref|coref|coref	5-14[0_22]|10-5[54_23]|5-14[0_22]|10-5[54_23]
5-7	358-365	disease	object[21]|abstract[22]|abstract[23]	new[21]|giv[22]|new[23]	_	_
5-8	366-369	but	object[21]|abstract[23]	new[21]|new[23]	_	_
5-9	370-374	type	object[21]|abstract[23]|abstract[24]	new[21]|new[23]|new[24]	coref	5-12[0_24]
5-10	375-376	1	object[21]|abstract[23]|abstract[24]	new[21]|new[23]|new[24]	_	_
5-11	377-380	and	_	_	_	_
5-12	381-385	type	abstract|abstract[27]	giv|new[27]	coref|coref	7-19[37_0]|7-19[37_0]
5-13	386-387	2	abstract[27]	new[27]	_	_
5-14	388-390	NF	abstract|abstract[27]	giv|new[27]	coref	6-2
5-15	391-398	account	abstract[27]	new[27]	_	_
5-16	399-402	for	abstract[27]	new[27]	_	_
5-17	403-406	the	abstract[27]	new[27]	_	_
5-18	407-411	vast	abstract[27]	new[27]	_	_
5-19	412-420	majority	abstract[27]	new[27]	_	_
5-20	421-423	of	abstract[27]	new[27]	_	_
5-21	424-429	cases	abstract[27]	new[27]	_	_
5-22	430-431	.	_	_	_	_

#Text=The disease manifestations can vary from very mild to severe .
6-1	432-435	The	event[29]	new[29]	_	_
6-2	436-443	disease	abstract|event[29]	giv|new[29]	coref	10-1
6-3	444-458	manifestations	event[29]	new[29]	_	_
6-4	459-462	can	_	_	_	_
6-5	463-467	vary	_	_	_	_
6-6	468-472	from	_	_	_	_
6-7	473-477	very	_	_	_	_
6-8	478-482	mild	_	_	_	_
6-9	483-485	to	_	_	_	_
6-10	486-492	severe	_	_	_	_
6-11	493-494	.	_	_	_	_

#Text=Major symptoms include growths on and under the skin ; skin pigmentations called café au lait spots in type 1 ; acoustic nerve tumors and consequent hearing loss in type 2 .
7-1	495-500	Major	abstract[30]	new[30]	_	_
7-2	501-509	symptoms	abstract[30]	new[30]	_	_
7-3	510-517	include	_	_	_	_
7-4	518-525	growths	abstract[31]	new[31]	appos	7-22[40_31]
7-5	526-528	on	abstract[31]	new[31]	_	_
7-6	529-532	and	abstract[31]	new[31]	_	_
7-7	533-538	under	abstract[31]	new[31]	_	_
7-8	539-542	the	abstract[31]|object[32]	new[31]|giv[32]	appos	7-11[33_32]
7-9	543-547	skin	abstract[31]|object[32]	new[31]|giv[32]	_	_
7-10	548-549	;	_	_	_	_
7-11	550-554	skin	object[33]	giv[33]	_	_
7-12	555-568	pigmentations	object[33]	giv[33]	_	_
7-13	569-575	called	_	_	_	_
7-14	576-580	café	place	new	_	_
7-15	581-583	au	place[36]	new[36]	_	_
7-16	584-588	lait	abstract|place[36]	new|new[36]	_	_
7-17	589-594	spots	place[36]	new[36]	_	_
7-18	595-597	in	_	_	_	_
7-19	598-602	type	abstract[37]	giv[37]	coref	11-1[61_37]
7-20	603-604	1	abstract[37]	giv[37]	_	_
7-21	605-606	;	_	_	_	_
7-22	607-615	acoustic	object[39]|abstract[40]	giv[39]|giv[40]	coref|coref	9-7[50_39]|9-7[50_39]
7-23	616-621	nerve	abstract|object[39]|abstract[40]	new|giv[39]|giv[40]	_	_
7-24	622-628	tumors	object[39]|abstract[40]	giv[39]|giv[40]	_	_
7-25	629-632	and	abstract[40]	giv[40]	_	_
7-26	633-643	consequent	abstract[40]	giv[40]	_	_
7-27	644-651	hearing	abstract[40]	giv[40]	_	_
7-28	652-656	loss	abstract[40]	giv[40]	_	_
7-29	657-659	in	abstract[40]	giv[40]	_	_
7-30	660-664	type	abstract[40]|abstract[41]	giv[40]|new[41]	_	_
7-31	665-666	2	abstract[40]|abstract[41]	giv[40]|new[41]	_	_
7-32	667-668	.	_	_	_	_

#Text=Growths can affect nearly all parts of the body , and pressure on nearby structures can cause a wide variety of complications .
8-1	669-676	Growths	event	new	_	_
8-2	677-680	can	_	_	_	_
8-3	681-687	affect	_	_	_	_
8-4	688-694	nearly	_	_	_	_
8-5	695-698	all	abstract[43]	new[43]	_	_
8-6	699-704	parts	abstract[43]	new[43]	_	_
8-7	705-707	of	abstract[43]	new[43]	_	_
8-8	708-711	the	abstract[43]|object[44]	new[43]|new[44]	coref	19-22[109_44]
8-9	712-716	body	abstract[43]|object[44]	new[43]|new[44]	_	_
8-10	717-718	,	_	_	_	_
8-11	719-722	and	_	_	_	_
8-12	723-731	pressure	abstract[45]	new[45]	_	_
8-13	732-734	on	abstract[45]	new[45]	_	_
8-14	735-741	nearby	abstract[45]|abstract[46]	new[45]|new[46]	coref	16-11[90_46]
8-15	742-752	structures	abstract[45]|abstract[46]	new[45]|new[46]	_	_
8-16	753-756	can	_	_	_	_
8-17	757-762	cause	_	_	_	_
8-18	763-764	a	abstract[47]	new[47]	_	_
8-19	765-769	wide	abstract[47]	new[47]	_	_
8-20	770-777	variety	abstract[47]	new[47]	_	_
8-21	778-780	of	abstract[47]	new[47]	_	_
8-22	781-794	complications	abstract[47]|abstract	new[47]|new	_	_
8-23	795-796	.	_	_	_	_

#Text=There is a small risk that the tumors transform into malignant cancerous lesions .
9-1	797-802	There	_	_	_	_
9-2	803-805	is	_	_	_	_
9-3	806-807	a	abstract[49]	new[49]	_	_
9-4	808-813	small	abstract[49]	new[49]	_	_
9-5	814-818	risk	abstract[49]	new[49]	_	_
9-6	819-823	that	_	_	_	_
9-7	824-827	the	object[50]	giv[50]	coref	17-2[0_50]
9-8	828-834	tumors	object[50]	giv[50]	_	_
9-9	835-844	transform	_	_	_	_
9-10	845-849	into	_	_	_	_
9-11	850-859	malignant	object[51]	new[51]	_	_
9-12	860-869	cancerous	object[51]	new[51]	_	_
9-13	870-877	lesions	object[51]	new[51]	_	_
9-14	878-879	.	_	_	_	_

#Text=NF is one of the most common single-gene human diseases ; around 1 in 2,500-4,000 live births are affected by NF-1 , whereas NF-2 occurs in about 1 in 50,000-120,000 .
10-1	880-882	NF	abstract	giv	coref	12-7
10-2	883-885	is	_	_	_	_
10-3	886-889	one	abstract[53]	new[53]	_	_
10-4	890-892	of	abstract[53]	new[53]	_	_
10-5	893-896	the	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-6	897-901	most	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-7	902-908	common	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-8	909-920	single-gene	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-9	921-926	human	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-10	927-935	diseases	abstract[53]|abstract[54]	new[53]|giv[54]	_	_
10-11	936-937	;	abstract[53]	new[53]	_	_
10-12	938-944	around	abstract[53]	new[53]	_	_
10-13	945-946	1	abstract[53]	new[53]	_	_
10-14	947-949	in	abstract[53]	new[53]	_	_
10-15	950-961	2,500-4,000	abstract[53]|abstract	new[53]|new	_	_
10-16	962-966	live	event[56]	new[56]	_	_
10-17	967-973	births	event[56]	new[56]	_	_
10-18	974-977	are	_	_	_	_
10-19	978-986	affected	_	_	_	_
10-20	987-989	by	_	_	_	_
10-21	990-994	NF-1	substance	new	coref	13-5
10-22	995-996	,	_	_	_	_
10-23	997-1004	whereas	_	_	_	_
10-24	1005-1009	NF-2	abstract	new	coref	13-7[75_0]
10-25	1010-1016	occurs	_	_	_	_
10-26	1017-1019	in	_	_	_	_
10-27	1020-1025	about	time[59]	new[59]	_	_
10-28	1026-1027	1	time[59]	new[59]	_	_
10-29	1028-1030	in	_	_	_	_
10-30	1031-1045	50,000-120,000	quantity	new	_	_
10-31	1046-1047	.	_	_	_	_

#Text=Both type 1 and 2 are autosomal dominant conditions , meaning that only one copy of the mutated gene need be inherited to pass the disorder .
11-1	1048-1052	Both	abstract[61]	giv[61]	coref	11-7[62_61]
11-2	1053-1057	type	abstract[61]	giv[61]	_	_
11-3	1058-1059	1	abstract[61]	giv[61]	_	_
11-4	1060-1063	and	abstract[61]	giv[61]	_	_
11-5	1064-1065	2	abstract[61]	giv[61]	_	_
11-6	1066-1069	are	_	_	_	_
11-7	1070-1079	autosomal	abstract[62]	giv[62]	_	_
11-8	1080-1088	dominant	abstract[62]	giv[62]	_	_
11-9	1089-1099	conditions	abstract[62]	giv[62]	_	_
11-10	1100-1101	,	_	_	_	_
11-11	1102-1109	meaning	_	_	_	_
11-12	1110-1114	that	_	_	_	_
11-13	1115-1119	only	object[63]	new[63]	_	_
11-14	1120-1123	one	object[63]	new[63]	_	_
11-15	1124-1128	copy	object[63]	new[63]	_	_
11-16	1129-1131	of	object[63]	new[63]	_	_
11-17	1132-1135	the	object[63]|abstract[64]	new[63]|new[64]	coref	13-1[73_64]
11-18	1136-1143	mutated	object[63]|abstract[64]	new[63]|new[64]	_	_
11-19	1144-1148	gene	object[63]|abstract[64]	new[63]|new[64]	_	_
11-20	1149-1153	need	_	_	_	_
11-21	1154-1156	be	_	_	_	_
11-22	1157-1166	inherited	_	_	_	_
11-23	1167-1169	to	_	_	_	_
11-24	1170-1174	pass	_	_	_	_
11-25	1175-1178	the	abstract[65]	new[65]	coref	12-20[72_65]
11-26	1179-1187	disorder	abstract[65]	new[65]	_	_
11-27	1188-1189	.	_	_	_	_

#Text=A child of a parent with neurofibromatosis and an unaffected parent will have a 50 % chance of inheriting the disorder .
12-1	1190-1191	A	person[66]	new[66]	_	_
12-2	1192-1197	child	person[66]	new[66]	_	_
12-3	1198-1200	of	person[66]	new[66]	_	_
12-4	1201-1202	a	person[66]|person[67]	new[66]|new[67]	_	_
12-5	1203-1209	parent	person[66]|person[67]	new[66]|new[67]	_	_
12-6	1210-1214	with	person[66]|person[67]	new[66]|new[67]	_	_
12-7	1215-1232	neurofibromatosis	person[66]|person[67]|abstract	new[66]|new[67]|giv	coref	14-5[79_0]
12-8	1233-1236	and	person[66]|person[67]	new[66]|new[67]	_	_
12-9	1237-1239	an	person[66]|person[67]|person[69]	new[66]|new[67]|new[69]	_	_
12-10	1240-1250	unaffected	person[66]|person[67]|person[69]	new[66]|new[67]|new[69]	_	_
12-11	1251-1257	parent	person[66]|person[67]|person[69]	new[66]|new[67]|new[69]	_	_
12-12	1258-1262	will	_	_	_	_
12-13	1263-1267	have	_	_	_	_
12-14	1268-1269	a	abstract[71]	new[71]	_	_
12-15	1270-1272	50	abstract[71]	new[71]	_	_
12-16	1273-1274	%	quantity|abstract[71]	new|new[71]	coref	15-2[82_0]
12-17	1275-1281	chance	abstract[71]	new[71]	_	_
12-18	1282-1284	of	_	_	_	_
12-19	1285-1295	inheriting	_	_	_	_
12-20	1296-1299	the	abstract[72]	giv[72]	_	_
12-21	1300-1308	disorder	abstract[72]	giv[72]	_	_
12-22	1309-1310	.	_	_	_	_

#Text=The gene responsible for NF-1 and possibly NF-2 is thought to function as a tumor suppressor gene .
13-1	1311-1314	The	abstract[73]	giv[73]	_	_
13-2	1315-1319	gene	abstract[73]	giv[73]	_	_
13-3	1320-1331	responsible	abstract[73]	giv[73]	_	_
13-4	1332-1335	for	_	_	_	_
13-5	1336-1340	NF-1	abstract	giv	_	_
13-6	1341-1344	and	_	_	_	_
13-7	1345-1353	possibly	abstract[75]	giv[75]	_	_
13-8	1354-1358	NF-2	abstract[75]	giv[75]	_	_
13-9	1359-1361	is	_	_	_	_
13-10	1362-1369	thought	_	_	_	_
13-11	1370-1372	to	_	_	_	_
13-12	1373-1381	function	_	_	_	_
13-13	1382-1384	as	_	_	_	_
13-14	1385-1386	a	_	_	_	_
13-15	1387-1392	tumor	abstract	new	_	_
13-16	1393-1403	suppressor	person	new	_	_
13-17	1404-1408	gene	_	_	_	_
13-18	1409-1410	.	_	_	_	_

#Text=In most cases of neurofibromatosis 1 , patients can live normal and productive lives .
14-1	1411-1413	In	_	_	_	_
14-2	1414-1418	most	abstract[78]	new[78]	_	_
14-3	1419-1424	cases	abstract[78]	new[78]	_	_
14-4	1425-1427	of	abstract[78]	new[78]	_	_
14-5	1428-1445	neurofibromatosis	abstract[78]|abstract[79]	new[78]|giv[79]	coref	16-5[88_79]
14-6	1446-1447	1	abstract[78]|abstract[79]	new[78]|giv[79]	_	_
14-7	1448-1449	,	_	_	_	_
14-8	1450-1458	patients	person	new	coref	15-6
14-9	1459-1462	can	_	_	_	_
14-10	1463-1467	live	_	_	_	_
14-11	1468-1474	normal	abstract[81]	new[81]	_	_
14-12	1475-1478	and	abstract[81]	new[81]	_	_
14-13	1479-1489	productive	abstract[81]	new[81]	_	_
14-14	1490-1495	lives	abstract[81]	new[81]	_	_
14-15	1496-1497	.	_	_	_	_

#Text=In about 25-40 % of patients there is an associated learning disability with or without ADHD .
15-1	1498-1500	In	_	_	_	_
15-2	1501-1506	about	quantity[82]	giv[82]	_	_
15-3	1507-1512	25-40	quantity[82]	giv[82]	_	_
15-4	1513-1514	%	quantity[82]	giv[82]	_	_
15-5	1515-1517	of	quantity[82]	giv[82]	_	_
15-6	1518-1526	patients	quantity[82]|person	giv[82]|giv	_	_
15-7	1527-1532	there	_	_	_	_
15-8	1533-1535	is	_	_	_	_
15-9	1536-1538	an	abstract[85]	new[85]	_	_
15-10	1539-1549	associated	abstract[85]	new[85]	_	_
15-11	1550-1558	learning	abstract|abstract[85]	new|new[85]	_	_
15-12	1559-1569	disability	abstract[85]	new[85]	_	_
15-13	1570-1574	with	abstract[85]	new[85]	_	_
15-14	1575-1577	or	abstract[85]	new[85]	_	_
15-15	1578-1585	without	abstract[85]	new[85]	_	_
15-16	1586-1590	ADHD	abstract[85]|abstract	new[85]|new	_	_
15-17	1591-1592	.	_	_	_	_

#Text=In some cases of neurofibromatosis 2 , the damage to nearby vital structures , such as the cranial nerves and the brainstem , can be life-threatening .
16-1	1593-1595	In	_	_	_	_
16-2	1596-1600	some	abstract[87]	new[87]	_	_
16-3	1601-1606	cases	abstract[87]	new[87]	_	_
16-4	1607-1609	of	abstract[87]	new[87]	_	_
16-5	1610-1627	neurofibromatosis	abstract[87]|abstract[88]	new[87]|giv[88]	coref	19-6[103_88]
16-6	1628-1629	2	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
16-7	1630-1631	,	_	_	_	_
16-8	1632-1635	the	abstract[89]	new[89]	_	_
16-9	1636-1642	damage	abstract[89]	new[89]	_	_
16-10	1643-1645	to	abstract[89]	new[89]	_	_
16-11	1646-1652	nearby	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-12	1653-1658	vital	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-13	1659-1669	structures	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-14	1670-1671	,	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-15	1672-1676	such	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-16	1677-1679	as	abstract[89]|abstract[90]	new[89]|giv[90]	_	_
16-17	1680-1683	the	abstract[89]|abstract[90]|abstract[91]	new[89]|giv[90]|giv[91]	_	_
16-18	1684-1691	cranial	abstract[89]|abstract[90]|abstract[91]	new[89]|giv[90]|giv[91]	_	_
16-19	1692-1698	nerves	abstract[89]|abstract[90]|abstract[91]	new[89]|giv[90]|giv[91]	_	_
16-20	1699-1702	and	abstract[89]|abstract[90]|abstract[91]	new[89]|giv[90]|giv[91]	_	_
16-21	1703-1706	the	abstract[89]|abstract[90]|abstract[91]|object[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
16-22	1707-1716	brainstem	abstract[89]|abstract[90]|abstract[91]|object[92]	new[89]|giv[90]|giv[91]|new[92]	_	_
16-23	1717-1718	,	_	_	_	_
16-24	1719-1722	can	_	_	_	_
16-25	1723-1725	be	_	_	_	_
16-26	1726-1742	life-threatening	_	_	_	_
16-27	1743-1744	.	_	_	_	_

#Text=When tumors are causing pain or disfiguration , surgery is thus far the only proven beneficial treatment option .
17-1	1745-1749	When	_	_	_	_
17-2	1750-1756	tumors	object	giv	coref	19-20
17-3	1757-1760	are	_	_	_	_
17-4	1761-1768	causing	_	_	_	_
17-5	1769-1773	pain	abstract	new	_	_
17-6	1774-1776	or	_	_	_	_
17-7	1777-1790	disfiguration	event	new	_	_
17-8	1791-1792	,	_	_	_	_
17-9	1793-1800	surgery	abstract	new	coref	17-11[98_0]
17-10	1801-1803	is	_	_	_	_
17-11	1804-1808	thus	abstract[98]	giv[98]	_	_
17-12	1809-1812	far	abstract[98]	giv[98]	_	_
17-13	1813-1816	the	abstract[98]	giv[98]	_	_
17-14	1817-1821	only	abstract[98]	giv[98]	_	_
17-15	1822-1828	proven	abstract[98]	giv[98]	_	_
17-16	1829-1839	beneficial	abstract[98]	giv[98]	_	_
17-17	1840-1849	treatment	event|abstract[98]	new|giv[98]	_	_
17-18	1850-1856	option	abstract[98]	giv[98]	_	_
17-19	1857-1858	.	_	_	_	_

#Text=Reggie Bibbs is a 43-year-old-man living in Houston , Texas .
18-1	1859-1865	Reggie	person[99]	giv[99]	coref	27-1[146_99]
18-2	1866-1871	Bibbs	person[99]	giv[99]	_	_
18-3	1872-1874	is	_	_	_	_
18-4	1875-1876	a	person[100]	new[100]	_	_
18-5	1877-1892	43-year-old-man	person[100]	new[100]	_	_
18-6	1893-1899	living	person[100]	new[100]	_	_
18-7	1900-1902	in	person[100]	new[100]	_	_
18-8	1903-1910	Houston	person[100]|place[101]	new[100]|new[101]	coref	27-19[153_101]
18-9	1911-1912	,	person[100]|place[101]	new[100]|new[101]	_	_
18-10	1913-1918	Texas	person[100]|place[101]	new[100]|new[101]	_	_
18-11	1919-1920	.	_	_	_	_

#Text=Mr Bibbs was born with a genetic disease called neurofibromatosis ( NF ) , which causes him to develop tumors on his body ( see infobox on the right ) .
19-1	1921-1923	Mr	person[102]	new[102]	ana	19-17[0_102]
19-2	1924-1929	Bibbs	person[102]	new[102]	_	_
19-3	1930-1933	was	_	_	_	_
19-4	1934-1938	born	_	_	_	_
19-5	1939-1943	with	_	_	_	_
19-6	1944-1945	a	abstract[103]	giv[103]	coref	19-10[0_103]
19-7	1946-1953	genetic	abstract[103]	giv[103]	_	_
19-8	1954-1961	disease	abstract[103]	giv[103]	_	_
19-9	1962-1968	called	_	_	_	_
19-10	1969-1986	neurofibromatosis	abstract	giv	coref	19-12
19-11	1987-1988	(	_	_	_	_
19-12	1989-1991	NF	abstract	giv	coref	20-1
19-13	1992-1993	)	_	_	_	_
19-14	1994-1995	,	_	_	_	_
19-15	1996-2001	which	_	_	_	_
19-16	2002-2008	causes	_	_	_	_
19-17	2009-2012	him	person	giv	ana	19-22
19-18	2013-2015	to	_	_	_	_
19-19	2016-2023	develop	_	_	_	_
19-20	2024-2030	tumors	object	giv	_	_
19-21	2031-2033	on	_	_	_	_
19-22	2034-2037	his	person|object[109]	giv|giv[109]	ana|ana	20-13[0_109]|20-13[0_109]
19-23	2038-2042	body	object[109]	giv[109]	_	_
19-24	2043-2044	(	_	_	_	_
19-25	2045-2048	see	_	_	_	_
19-26	2049-2056	infobox	abstract	giv	_	_
19-27	2057-2059	on	_	_	_	_
19-28	2060-2063	the	abstract[111]	new[111]	_	_
19-29	2064-2069	right	abstract[111]	new[111]	_	_
19-30	2070-2071	)	_	_	_	_
19-31	2072-2073	.	_	_	_	_

#Text=NF can be a subtle disease , but in Bibbs ' case it has left him with a disfigured face and deformed leg .
20-1	2074-2076	NF	abstract	giv	coref	20-4[113_0]
20-2	2077-2080	can	_	_	_	_
20-3	2081-2083	be	_	_	_	_
20-4	2084-2085	a	abstract[113]	giv[113]	coref	26-2[0_113]
20-5	2086-2092	subtle	abstract[113]	giv[113]	_	_
20-6	2093-2100	disease	abstract[113]	giv[113]	_	_
20-7	2101-2102	,	_	_	_	_
20-8	2103-2106	but	_	_	_	_
20-9	2107-2109	in	_	_	_	_
20-10	2110-2115	Bibbs	person[114]|abstract[115]	new[114]|new[115]	ana|ana	20-16[0_114]|20-16[0_114]
20-11	2116-2117	'	person[114]|abstract[115]	new[114]|new[115]	_	_
20-12	2118-2122	case	abstract[115]	new[115]	_	_
20-13	2123-2125	it	object	giv	_	_
20-14	2126-2129	has	_	_	_	_
20-15	2130-2134	left	_	_	_	_
20-16	2135-2138	him	person	giv	ana	21-2
20-17	2139-2143	with	_	_	_	_
20-18	2144-2145	a	object[118]	new[118]	_	_
20-19	2146-2156	disfigured	object[118]	new[118]	_	_
20-20	2157-2161	face	object[118]	new[118]	_	_
20-21	2162-2165	and	_	_	_	_
20-22	2166-2174	deformed	object[119]	new[119]	_	_
20-23	2175-2178	leg	object[119]	new[119]	_	_
20-24	2179-2180	.	_	_	_	_

#Text=But he is happy with the way he looks , and does n't want to change his appearance to please other people .
21-1	2181-2184	But	_	_	_	_
21-2	2185-2187	he	person	giv	ana	21-8
21-3	2188-2190	is	_	_	_	_
21-4	2191-2196	happy	_	_	_	_
21-5	2197-2201	with	_	_	_	_
21-6	2202-2205	the	abstract[121]	new[121]	_	_
21-7	2206-2209	way	abstract[121]	new[121]	_	_
21-8	2210-2212	he	person	giv	ana	21-17
21-9	2213-2218	looks	_	_	_	_
21-10	2219-2220	,	_	_	_	_
21-11	2221-2224	and	_	_	_	_
21-12	2225-2229	does	_	_	_	_
21-13	2230-2233	n't	_	_	_	_
21-14	2234-2238	want	_	_	_	_
21-15	2239-2241	to	_	_	_	_
21-16	2242-2248	change	_	_	_	_
21-17	2249-2252	his	person|abstract[124]	giv|new[124]	ana|ana	22-1|22-1
21-18	2253-2263	appearance	abstract[124]	new[124]	_	_
21-19	2264-2266	to	_	_	_	_
21-20	2267-2273	please	_	_	_	_
21-21	2274-2279	other	person[125]	new[125]	_	_
21-22	2280-2286	people	person[125]	new[125]	_	_
21-23	2287-2288	.	_	_	_	_

#Text=He has launched a successful campaign entitled " Just Ask " , and that 's just what Wikinews did in a video-interview .
22-1	2289-2291	He	person	giv	_	_
22-2	2292-2295	has	_	_	_	_
22-3	2296-2304	launched	_	_	_	_
22-4	2305-2306	a	abstract[127]	new[127]	ana	22-14[0_127]
22-5	2307-2317	successful	abstract[127]	new[127]	_	_
22-6	2318-2326	campaign	abstract[127]	new[127]	_	_
22-7	2327-2335	entitled	_	_	_	_
22-8	2336-2337	"	_	_	_	_
22-9	2338-2342	Just	_	_	_	_
22-10	2343-2346	Ask	_	_	_	_
22-11	2347-2348	"	_	_	_	_
22-12	2349-2350	,	_	_	_	_
22-13	2351-2354	and	_	_	_	_
22-14	2355-2359	that	abstract	giv	_	_
22-15	2360-2362	's	_	_	_	_
22-16	2363-2367	just	_	_	_	_
22-17	2368-2372	what	_	_	_	_
22-18	2373-2381	Wikinews	organization	new	coref	23-6
22-19	2382-2385	did	_	_	_	_
22-20	2386-2388	in	_	_	_	_
22-21	2389-2390	a	object[130]	new[130]	_	_
22-22	2391-2406	video-interview	object[130]	new[130]	_	_
22-23	2407-2408	.	_	_	_	_

#Text=The interview was prepared by Wikinews reporter Michaël Laurent with the help of Bertalan Meskó ( who has a popular genetics and web 2.0 blog ) .
23-1	2409-2412	The	event[131]	new[131]	coref	24-19[143_131]
23-2	2413-2422	interview	event[131]	new[131]	_	_
23-3	2423-2426	was	_	_	_	_
23-4	2427-2435	prepared	_	_	_	_
23-5	2436-2438	by	_	_	_	_
23-6	2439-2447	Wikinews	organization|person[133]	giv|new[133]	_	_
23-7	2448-2456	reporter	person[133]	new[133]	_	_
23-8	2457-2464	Michaël	person[133]	new[133]	_	_
23-9	2465-2472	Laurent	person[133]	new[133]	_	_
23-10	2473-2477	with	_	_	_	_
23-11	2478-2481	the	abstract[134]	new[134]	_	_
23-12	2482-2486	help	abstract[134]	new[134]	_	_
23-13	2487-2489	of	abstract[134]	new[134]	_	_
23-14	2490-2498	Bertalan	abstract[134]|person[135]	new[134]|new[135]	_	_
23-15	2499-2504	Meskó	abstract[134]|person[135]	new[134]|new[135]	_	_
23-16	2505-2506	(	_	_	_	_
23-17	2507-2510	who	_	_	_	_
23-18	2511-2514	has	_	_	_	_
23-19	2515-2516	a	abstract[136]|abstract[137]	new[136]|new[137]	ana|ana	24-1[0_137]|24-1[0_137]
23-20	2517-2524	popular	abstract[136]|abstract[137]	new[136]|new[137]	_	_
23-21	2525-2533	genetics	abstract[136]|abstract[137]	new[136]|new[137]	_	_
23-22	2534-2537	and	abstract[137]	new[137]	_	_
23-23	2538-2541	web	abstract[137]|abstract|place[139]	new[137]|new|new[139]	_	_
23-24	2542-2545	2.0	abstract[137]|place[139]	new[137]|new[139]	_	_
23-25	2546-2550	blog	abstract[137]|place[139]	new[137]|new[139]	_	_
23-26	2551-2552	)	_	_	_	_
23-27	2553-2554	.	_	_	_	_

#Text=Their questions were sent to a close friend of Mr. Bibbs , Lou Congelio , who kindly conducted the interview .
24-1	2555-2560	Their	abstract|abstract[141]	giv|new[141]	_	_
24-2	2561-2570	questions	abstract[141]	new[141]	_	_
24-3	2571-2575	were	_	_	_	_
24-4	2576-2580	sent	_	_	_	_
24-5	2581-2583	to	_	_	_	_
24-6	2584-2585	a	person[142]	new[142]	_	_
24-7	2586-2591	close	person[142]	new[142]	_	_
24-8	2592-2598	friend	person[142]	new[142]	_	_
24-9	2599-2601	of	person[142]	new[142]	_	_
24-10	2602-2605	Mr.	person[142]	new[142]	_	_
24-11	2606-2611	Bibbs	person[142]	new[142]	_	_
24-12	2612-2613	,	person[142]	new[142]	_	_
24-13	2614-2617	Lou	person[142]	new[142]	_	_
24-14	2618-2626	Congelio	person[142]	new[142]	_	_
24-15	2627-2628	,	_	_	_	_
24-16	2629-2632	who	_	_	_	_
24-17	2633-2639	kindly	_	_	_	_
24-18	2640-2649	conducted	_	_	_	_
24-19	2650-2653	the	event[143]	giv[143]	coref	25-1[144_143]
24-20	2654-2663	interview	event[143]	giv[143]	_	_
24-21	2664-2665	.	_	_	_	_

#Text=The interview
25-1	2666-2669	The	event[144]	giv[144]	_	_
25-2	2670-2679	interview	event[144]	giv[144]	_	_

#Text=On neurofibromatosis
26-1	2680-2682	On	_	_	_	_
26-2	2683-2700	neurofibromatosis	abstract	giv	coref	28-15

#Text=Reggie Bibbs : My name is Reggie Bibbs , I am 43 years old and I live in Houston , Texas .
27-1	2701-2707	Reggie	person[146]	giv[146]	coref	27-7[149_146]
27-2	2708-2713	Bibbs	person[146]	giv[146]	_	_
27-3	2714-2715	:	_	_	_	_
27-4	2716-2718	My	person|abstract[148]	acc|new[148]	ana|ana	27-10|27-10
27-5	2719-2723	name	abstract[148]	new[148]	_	_
27-6	2724-2726	is	_	_	_	_
27-7	2727-2733	Reggie	person[149]	giv[149]	_	_
27-8	2734-2739	Bibbs	person[149]	giv[149]	_	_
27-9	2740-2741	,	_	_	_	_
27-10	2742-2743	I	person	giv	ana	27-16
27-11	2744-2746	am	_	_	_	_
27-12	2747-2749	43	time[151]	new[151]	_	_
27-13	2750-2755	years	time[151]	new[151]	_	_
27-14	2756-2759	old	_	_	_	_
27-15	2760-2763	and	_	_	_	_
27-16	2764-2765	I	person	giv	_	_
27-17	2766-2770	live	_	_	_	_
27-18	2771-2773	in	_	_	_	_
27-19	2774-2781	Houston	place[153]	giv[153]	_	_
27-20	2782-2783	,	place[153]	giv[153]	_	_
27-21	2784-2789	Texas	place[153]	giv[153]	_	_
27-22	2790-2791	.	_	_	_	_

#Text=Wikinews : Can you explain to our readers in simple terms what exactly is neurofibromatosis ?
28-1	2792-2800	Wikinews	_	_	_	_
28-2	2801-2802	:	_	_	_	_
28-3	2803-2806	Can	_	_	_	_
28-4	2807-2810	you	person	acc	_	_
28-5	2811-2818	explain	_	_	_	_
28-6	2819-2821	to	_	_	_	_
28-7	2822-2825	our	person|person[156]	acc|new[156]	_	_
28-8	2826-2833	readers	person[156]	new[156]	_	_
28-9	2834-2836	in	_	_	_	_
28-10	2837-2843	simple	abstract[157]	new[157]	_	_
28-11	2844-2849	terms	abstract[157]	new[157]	_	_
28-12	2850-2854	what	_	_	_	_
28-13	2855-2862	exactly	_	_	_	_
28-14	2863-2865	is	_	_	_	_
28-15	2866-2883	neurofibromatosis	abstract	giv	_	_
28-16	2884-2885	?	_	_	_	_
